Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821586-24-000020
Filing Date
2024-05-07
Accepted
2024-05-07 08:02:56
Documents
81
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnlk-20240331.htm   iXBRL 10-Q 933197
2 EX-31.1 mltx_2024q1xex311dasilva.htm EX-31.1 10301
3 EX-31.2 mltx_2024q1xex312bodenstedt.htm EX-31.2 10213
4 EX-32.1 mltx_2024q1xex321dasilva.htm EX-32.1 4946
5 EX-32.2 mltx_2024q1xex322bodenstedt.htm EX-32.2 4883
  Complete submission text file 0001821586-24-000020.txt   6094973

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlk-20240331.xsd EX-101.SCH 44589
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnlk-20240331_cal.xml EX-101.CAL 69139
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnlk-20240331_def.xml EX-101.DEF 271997
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlk-20240331_lab.xml EX-101.LAB 559342
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlk-20240331_pre.xml EX-101.PRE 436603
85 EXTRACTED XBRL INSTANCE DOCUMENT mnlk-20240331_htm.xml XML 696710
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39630 | Film No.: 24919697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)